Member Info for AquaeSulis01

Trek, they are saying that they weren't bothered about testing for Antimony levels but the invasion of Ukraine has highlighted the importance of sourcing it from other locations than China and Russia I suspect.

https://www.forbes.com/sites/davidblackmon/2021/05/06/antimony-the-most-important-mineral-you-never-heard-of/

Sebastian James, chief executive of Boots, told the BBC: "Over the pandemic we saw a lot less colour cosmetics in our trade, lipsticks and so on, and a lot more spend on self care, so skin care, haircare, and particularly what we call expert skin care.
https://www.telegraph.co.uk/business/2022/04/21/women-turning-away-make-up-lockdowns-change-beauty-habits/

Good to hear you are still afloat belgrano and faring better than your namesake which was sunk after moving from perceived choppier waters to calmer climes. As for Putin's war in Ukraine coming to a speedy conclusion or ever seeing any dividends, not something I would personally feel comfortable speculating on

A lot of the regular HNWI 's such as belgrano, who has sunk without trace on here, have drawn down their holdings and been playing Russian Roulette with PolyMetal resources I believe. I know July should see an announcement about the toothpaste/mouthwash Manchester University R&D work, and I suspect an update on the actual sales of axisbiotix should follow about the same time. Apart from that, Skinbiotix news re the Croda VIP clients could drop anytime although the end of 2022 is the forecast date from any Royalty revenues from that source.

One things for sure, you wont have to wait years to get back to where you were, if the share price doesn't quicky rebound then a takeover at this level is odds on now I would say

https://www.moreaboutadvertising.com/2022/03/itvs-streaming-own-goal-could-lead-to-takeover-trouble/

https://www.defenseworld.net/2022/04/14/itv-plc-plans-dividend-of-0-38-otcmktsitvpy.html

Cut the Board some slack, you're all talking as if the strategy has already failed, all business's have to either evolve or eventually die. This is quite a balanced report on the move to the AVOD market
https://thegrovemedia.co.uk/we-give-the-lowdown-on-itvx-itvs-new-avod-led-streaming-platform/

Blue, as someone sat on th esidelines evaluating this company, the thing that catches my eye in the report is "Cline & Associates (GCA) assigned Geological Chance of Success (GCoS) of 32%. After this independent assessment, the Company completed a gas cloud study and post-stack seismic inversion study that it believes further mitigates risk and increases the GCoS to 41%.". Doesn't that mean that there is a 59% chance of the drill not being a success making this a very risky proposition at this stage, i.e. what mitigating factors are there to safeguard the sp if the drilling disappoints?

leapfroggy, I have noticed that myself, but you need to bear in mind that Stuart has consciously opted for a targeted marketing strategy rather than spend shed loads of money on a pay per click company with a high advert spend along with google shopping results on a D2C site. Web data is split down into different categorisations by search algorithm; content that fulfils a requirement for a content type. Generally speaking, you need to correctly structure everything in a way that Google understands what it is you provide. Then you also have competition to factor in; something like SEMrush will show you what your competition is and give you a research opportunity to read the site code to see how it compares to yours as well as the actual content and content types used. So basically must be prepared to potentially have a whole new site built which would be expensive and wont guarantee success. Psoriasis and treatment is always going to be primarily about medical advice with google quite rightly ranking those sites as page 1 material and quite rightly so.

Suspect he has to be a non-board CEO whilst he remains MD of Goldoz, another publicly listed Gold explorer, to guard against conflict of interest

Soaring gas prices fast-forward the economics for hydrogen
Low-carbon fuel seen as key to energy security, climate goals
ByWill Mathis, Rachel Morison, and Vanessa Dezem
10 April 2022, 07:00 BST
Listen to this article
5:36
Share this article
Follow the authors
@MathisWilliam
+ Get alerts forWill Mathis
@rachelmorison
+ Get alerts forRachel Morison
@vanessadezem
+ Get alerts forVanessa Dezem
In this article
NG1
Generic 1st 'NG' Future
6.34USD/MMBtu+0.06+1.02%
FMG
FORTESCUE METALS
21.19AUD-0.64-2.93%
CL1
WTI Crude
94.38USD/bbl.-3.88-3.95%
1923561D
HY24
Private Company
ORSTED
ORSTED A/S
830.60DKK-14.50-1.72%
Open
Europe’s push to wean itself off Russian natural gas is sparking billions of dollars in new commitments toward building a market for low-carbon hydrogen.

A nearly 450% jump in European gas prices the past year made the green fuel of the future cost-competitive about a decade ahead of schedule, according to BloombergNEF. Now, investment funds are joining governments and utilities in ambitious plans to make hydrogen a viable substitute for fossil fuels in manufacturing, transportation and heating.
“It’s kind of a tipping point,” said Phil Caldwell, chief executive officer at Ceres Power Holdings Plc, a U.K.-based hydrogen technology company. “You’re going to see that capital coming in on a big scale now. There’s no turning back.”
https://www.bloomberg.com/news/articles/2022-04-10/russia-s-invasion-supercharges-push-to-make-a-new-green-fuel

elrico,

Whilst I agree with the general tenet of your response I would just add that with two thirds of the performance options already having been achieved, Stuart is unlikely to be accused of trying to achieve the third option, 80p target for more than 30 days, on the back of a share purchase at the current sp. Also, Cathal's purchase may well not of arrested the declining sp, but it was a clear statement that he believed the company was seriously undervalued (walk the walk not just talk the talk) providing genuine LTH's and prospective new investors with the confidence that there are much better days ahead.

"On 18 April 2019, 3,892,083 options were granted at an exercise price of £0.18 per share and are exercisable based upon achieving three
performance conditions, with a third of the options being granted for each condition. The performance conditions are based on the
achievement of an 40p share price for more than a 30-day continuous period, the achievement of an 80p share price for more than a 30-day
continuous period, and on the commercial viability of developed products, or the entering into of joint ventures, partnerships, collaborations
or agreements for the sale or licensing of products. "

No, you had to buy them before the ex dividend date

elrico, not sure I buy the old argument that there is almost a permanent closed window for Directors in very small businesses to buy shares; others such as Paul Johnson of POW, who has far more projects spinning than Stuart, have managed to find a suitable window.
Negotiations have been going on for over 2 years with potential partners for Medibiotix without any market notifiable news, whilst Oral Healthcare results from Manchester University are not expected until July. Stuart in a podcast with you expressed a view that the sp post the results update was dramatically under valued so it would have been good if he backed that view up with a purchase. Anyway, let's see whether any significant news is released over the next 2 mths and then we can make our minds up whether there is any significant breaking news that insiders are sat on; after all you may well be right in your view and we will all be very happy if you are

Concur with that summary Lord. Every reason to be optimistic re the Probiotix Health valuation now that marketing has finally been ramped up for the LPLDL ingredient and cholbiome end products, and it also has its own fallback if the sp drops significantly in 9 mths time reducing the M/C accordingly as surely Seed Health will snap the company up to save on future royalties in its DS01 product?

With H&L and still waiting. Anon, plenty of room for the sp to rise as well on the Sweetbiotix news and I guess that is the factor supporting the sp post the split

Concur with that bitcoin. Certainly taking their time to announce the decision on the selection from a shortlist of 3 announced weeks ago. Hope that they haven't referred the cvs off to the assay labs to be verified otherwise will take months :)

This is a general market pullback, over a tenth of the footsie 100 has fallen by similar margins today

Hi Elrico,
That makes it all the more surprising that the study did not include a simple question do you also suffer from psoriatic arthritis and at the end of the study have you noticed any improvement in your mobility to a great extent, moderate improvement or none at all? I wonder if the opportunity could be taken by Stuart through the US NPF to identify Psoriasis sufferers with noticeable Psoriatic Arthritis and offer them a free two month supply of axisbiotix in exchange for them agreeing to share their results with other NPF members; the publicity from that would surely pay for itself a thousandfold?

The Canada Pension Plan Investment Board have reduced their short